Scynexis (SCYX) Cash & Equivalents (2013 - 2026)

Scynexis (SCYX) has reported Cash & Equivalents for 14 consecutive years, with $71.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 52.9% year-over-year to $71.1 million; the trailing twelve-month figure through Jun 2026 stood at $71.1 million (up 52.9% YoY), and the FY2025 full-year result was $21.3 million, up 32.45% from the prior year.
• Cash & Equivalents retreated to $71.1 million in Q2 2026 per SCYX's latest filing, from $72.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $118.7 million in Q2 2022 and bottomed at $16.1 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $68.0 million across 5 years, with a median of $71.8 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents sank 56.15% in 2022, then jumped 71.9% in 2024.
• Over 5 years, Cash & Equivalents stood at $45.8 million in 2022, then dropped by 25.68% to $34.0 million in 2023, then sank by 52.86% to $16.1 million in 2024, then surged by 32.45% to $21.3 million in 2025, then soared by 234.45% to $71.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $71.1 million, $72.4 million, and $21.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.